American Indian Health Commission for Washington State October 1, 2015



Similar documents
2015 REPORT Steven W. Schierholt, Esq. Executive Director

Washington. Contact Information. Statistics. Technological Capabilities

Massachusetts Substance Abuse Policy and Practices. Senator Jennifer L. Flanagan Massachusetts Worcester and Middlesex District

Colorado Prescription Drug Monitoring Program. Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy

Drug Diversion. Controlled Substance Prescribing and Diversion

How To Get A Prescription In Rhode Island

MEETING OF THE DRUG SAFETY AND RISK MANAGEMENT ADVISORY COMMITTEE MEETING: RISKS AND BENEFITS OF HYDROCODONE COMBINATION ANALGESIC PRODUCTS

CHAPTER Section 34 of P.L.1970, c.226 (C.24:21-34) is amended to read as follows:

What Parents Need to Know

Prescription drug abuse trends. Minnesota s Prescription Monitoring Program. Minnesota Rural Health Conference June 25, 2013 Duluth

Washington State Interagency Opioid Working Plan

Prescription Drug Monitoring Program Center of Excellence at Brandeis

PLEASE READ. The official text of New Jersey Statutes can be found through the home page of the New Jersey Legislature

Prescription Drug Monitoring Programs Bill Status Update

Substance Use: Addressing Addiction and Emerging Issues

Massachusetts. Contact Information. Statistics. Technological Capabilities

Prescription Drug Monitoring Programs

The Heroin and Opioid Epidemic in Northeast Ohio: One Year Report to the Community

Prescription Opioid Overdose & Misuse in Oregon

Georgia. Contact Information. Office: Fax: Statistics. Technological Capabilities

Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013

UNM Pain Center: Addressing New Mexico s Public Health Crises of Pain, Addiction, and Unintentional Opioid Overdose Deaths

HEALTH PROFESSIONS: CONSEQUENCES OF DUI PROSECUTION & CONVICTION

Naloxone Distribution for Opioid Overdose Prevention

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE

Prescribers required to check PDMP before first prescription for Controled Substances for new patient.

Delaware. Division of Professional Regulation, Office of Controlled Substances Professional Licensing Agency

Governor s Task Force on Mental Health and Substance Use.

Strong States, Strong Nation POLICY OPTIONS TO DECREASE RISKS FROM THE USE OF METHADONE AS A PAIN RELIEVER

Drug overdose death rates by state per 100,000 people (2008) SOURCE: National Vital Statistics System, 2008

Medical Malpractice Treatment Alprazolam benzodiazepine - A Case Study

Implementation of Florida s PDMP. Rebecca Poston Program Manager

South Dakota Prescription Drug Monitoring Program (SD PDMP) Learning Objectives

Prescription Drug Abuse and Pain Management Clinics 2015 Report to the 109 th Tennessee General Assembly

Electronic Prescribing In New York State

Maryland. Department of Health and Mental Hygiene, Alcohol and Drug Abuse Administration Substance Abuse Agency

Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas

3/27/2012. Supply and Demand: The Substance Abuse/Misuse Market Triangle

02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION

Data-Driven Multi-Disciplinary Approaches to Reducing Rx Abuse, BJA Award FY 2014

Trends of Opioid Misuse and Diversion: Lessons from the United States

PRESCRIPTION PAINKILLER OVERDOSES

Section 303(g)(2)(G) of the Controlled Substances Act (21 U.S.C. 823(g)(2)(G)) is amended. (1) by striking clause (ii) and inserting the following:

Idaho. Contact Information. Fax: (208) Statistics. Technological Capabilities

WHAT WE KNOW. Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE

Arkansas Emergency Department Opioid Prescribing Guidelines

Alaska Prescription Drug Monitoring Program

Implementing Prescribing Guidelines in the Emergency Department. April 16, 2013

STATE PLAN TO PREVENT AND TREAT PRESCRIPTION DRUG ABUSE RECOMMENDATION SUMMARY Governor s Prescription Drug Abuse Prevention Council

HOUSE OF REPRESENTATIVES FINAL BILL ANALYSIS SUMMARY ANALYSIS

Prescription Drug Abuse and Overdose: Public Health Perspective

SAMHSA Initiatives to Educate Prescribers and Consumers and Treatment Resources

Prescription Drug Monitoring Programs: Adopting Best & Promising PDMP Practices

PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA

JAN poisonings, commonly referred to as drug overdoses, are one of. the leading causes of injury-related mortality in Hawaii.

Opioids for Pain Treatment. Opioids for Chronic Pain and Addiction Treatment. Outline for Today. Opioids for pain treatment

What Is a Prescriber s Role in Preventing the Diversion of Prescription Drugs?

OBJECTIVES. ! Understand the rising epidemic of prescription drug abuse in Wyoming. ! Know how to access and use reports from the WORx program

The Cost of Pain and Economic Burden of Prescription Misuse, Abuse and Diversion. Angela Huskey, PharmD, CPE

Palmer MacKie, MD MS Director, Integrative Pain Program, Eskenazi Department of Medicine, IUSOM

FREQUENTLY ASKED QUESTIONS

The Arizona Prescription Drug Misuse and Abuse Initiative: A Multi-Systems Approach to Addressing Prescription Drug Misuse and Abuse

Heroin Addiction. Kim A. Drury RN, MSN

Mayor s Task Force On Prescription Painkiller Abuse

SCOPE OF PRACTICE FOR ARNPS

2015 ANNUAL REVIEW OF PRESCRIPTION MONITORING PROGRAMS

Part 1: Opioids and Overdose in the U.S. and New Mexico. Training: New Mexico Pharmacist Prescriptive Authority for Naloxone Protocol 7/15/2015

Medication is not a part of treatment.

INFO Brief. Prescription Opioid Use: Pain Management and Drug Abuse In King County and Washington State

AN ACT RELATING TO HEALTH INSURANCE; AMENDING A SECTION OF THE NEW MEXICO INSURANCE CODE TO PROVIDE FOR FREEDOM OF CHOICE OF

Information for Pharmacists

Arizona s Emergency Department Prescribing Guidelines

Oregon Health Care Regulatory Agencies

The Current State of Drug Abuse Across the Nation. December 12, 2015

REFERENCE ACTION ANALYST STAFF DIRECTOR or BUDGET/POLICY CHIEF. 2) Health & Human Services Committee 14 Y, 0 N Holt Calamas

Prescription Drug Monitoring Program Annual Report

Illinois. Contact Information. Office: Fax: Statistics. Technological Capabilities

SUBOXONE /VIVITROL WEBINAR. Educational Training tool concerning the Non-Methadone Medication Assisted Treatment Policy that is Effective on 1/1/12

CDC s Prevention Efforts to Address Prescription Opioid Epidemic

Transcription:

American Indian Health Commission for Washington State October 1, 2015

States with more opioid pain reliever sales tend to have more drug overdose deaths Death rate, 2011, National Vital Statistics System. Opioid pain reliever sales rate, 2013, DEA s Automation of Reports and Consolidated Orders System

Nation Wide: Drug overdoses have surpassed motor vehicle crashes as the leading cause of injury death

Sources:, Death Certificates and Hospital Discharge Data

Dramatic increase in overdose deaths related to opioid pain relievers CDC, National Center for Health Statistics, National Vital Statistics System

Balloon Effect: squeeze a balloon in one place, it inflates elsewhere Accelerated increase in the number of deaths attributed to heroin overdose annually since 2008.

Key Surveillance Needs Respond to emerging issues

2011 Opioid deaths = 400 400X12= 4,800 400X25= 10,000 400X105= 42,000 400X659= 263,600 Total 320,400

Prescriptions Dispensed 12 14 Rank by most recent year Generic Name 2014 RX 2013 RX 2012 RX HYDROCODONE/ ACETAMINOPHEN 2,775,054 2,814,288 3,007,054 OXYCODONE HCL 1,043,239 962,909 927,899 OXYCODONE HCL/ACETAMINOPHEN 847,054 854,344 922,408 ZOLPIDEM TARTRATE 791,303 834,515 916,823 ALPRAZOLAM 645,435 638,556 657,064 LORAZEPAM 644,463 457,689 644,306 DEXTROAMPHETAMINE/ AMPHETAMINE 580,426 518,964 475,749 CLONAZEPAM 528,338 518,349 529,671 METHYLPHENIDATE HCL 423,117 414,548 412,848 MORPHINE SULFATE 336,520 328,015 333,717 TRAMADOL HCL 308,524

WA Prescription Monitoring Program

History Legislation was passed in 2007 (RCW 70.225) Federal funding was obtained in October 2010 to start implementing the program Rules were adopted in July 2011 (WAC 246-470) DOH contracted with an application service provider for data collection and reporting in July 2011 An additional federal award was obtained in October 2011 to finalize implementation HB 1565 (2013) provided ongoing funding through the Medicaid Fraud Penalty Account. The signed operating budget included funding for the PMP from this account and from HCA.

System Overview - Weekly Submission Dispensers - Schedules II-V - ASAP 4.2 * Veterinarians have separate requirements Reports Data Submitted Pharmacists Sent State PMP Prescribers Reports Reports Sent Sent Law Enforcement & Licensing *Other groups may also receive reports other than those listed

DOH Goals for Washington s PMP Help Prevent Prescription Drug Overdoses! Give practitioners an additional tool that provides more information for making patient care decisions. Data can help healthcare providers recognize patterns of misuse and addiction ensuring SBIRT opportunities are not missed. Make sure those in need of scheduled prescription drugs receive them. Educate the population on the dangers of misusing prescription drugs. Curb the illicit use of prescription drugs.

Master Account Registrations Pharmacist 4,679 Nurse Practitioner 1,973 Medical Doctor 6,208 Dentist 1,377 Medical Limited 380 Dental Community Resident 0 Physician Fellowship 4 Dental UW Resident 6 Teaching/Research 3 Dental Faculty 1 Osteopathic Physician 628 Podiatric Physician 96 Osteopathic Limited 59 Naturopathic Physician 65 Physician Assistant 1,272 Optometrist 45 Osteopathic Phys. Assist. 23 Veterinarian 63 06/30/15 12,203 total prescribers registered (31.09% of DEA Registrants) 741 Provider Master Accounts Linked to at least 1 Delegate Account

WA DEA Registrants w/ and w/out PMP Accounts DEA Registrants by Level 40000 40,000 35000 35,000 30000 30,000 25000 20000 DEA w/ No PMP Registered DEA & PMP 25,000 20,000 Mid Full 15000 15,000 10000 10,000 5000 5,000 0 1 0 1 Less than half, only 31%, of WA prescribers are registered to access the PMP 69% of WA prescribers CANNOT verify their patient s CS history on PMP

Delegate Account Registrations Chemical Dependency Prof. 14 Med. Assistant Certified 702 Med Assist. Hemodialysis 0 Med Assist. Registered 51 Med Assist. Phlebotomist 11 Med Assist. Interim 32 Licensed Practical Nurse 141 Registered Nurse 763 Nursing Assistant Reg. 18 Nursing Assistant Cert. 13 Dental Assistant 8 06/30/15 1,824 total delegate accounts registered Dental Hygienists 4 Expanded Func. Dental Aux. 2 Mental Health Counselor 8 Marriage & Family Therapist 2 Psychologist License 24 Social Worker Advanced 12 Social Worker Associate 8 Counselor Agency Affiliated 5 X-Ray Technician 3 Athletic Trainer 3 Delegates are able to access the system and check patient records on behalf of the prescriber

Clinical Steps for Ensuring Safe Rx Use KNOW the patient s Rx history VERIFY the patient is receiving appropriate care PREVENT harmful drug interactions EVALUATE patients for risk of misuse/abuse of drugs PROTECT your practice by providing the best care EDUCATE patients on how to safely use their medications

2015 AMDG Guideline on Prescribing Opioids for Pain Updated guide from Washington State Agency Medical Director s Group Guide covers Prescribing Opioids: In the Acute and SubAcute Phases For Perioperative Pain For Chronic Non-Cancer Pain and many other related topics http://www.agencymeddirectors.wa.gov/opioiddosing.asp

Key PMP Benefits for Providers CHECK for misuse, multiple prescribers (coordinate care) CHECK for drug interactions or other harm USE reports for compliance with treatment contracts CHECK history of transactions linked to DEA number fraudulent scripts and monthly reporting

Key PMP Practices to Consider DELEGATE prescription look-up to other staff to save time TRAIN your staff by using a PMP champion REGISTER accounts for all appropriate staff with the PMP RETAIN documentation by placing a copy in the patient file or into an EHR system

Top 5 Times to Check the PMP 1. New patients 2. When prescribing a controlled substance 3. Patient is in substance abuse treatment 4. Chronic pain patients ensure treatment contract compliance 5. For evaluating episodic care

Post PMP Review Action Steps For at risk patients: TALK with the patient to determine reasons for at risk behaviors SBIRT opportunity? COORDINATE care with the other providers listed on the report CONSIDER using a patient treatment agreement VERIFY the prescriptions listed match your records REFER your patient to treatment or other specialty care EDUCATE patients on the risks of opioid overdose

Customer Satisfaction Survey Comments This has changed my practice as an ER Physician. No single thing in the last 10 years has had such a positive impact on my practice and my patients as this program, so thank you! I really am grateful to have the PMP active. It is absolutely essential for any Pain Management practice and essential for any physician prescribing controlled substances. I believe that this program has literally saved the lives of several of my patients. I have been floored by the number of narcotics dozens of teenaged girls have been obtaining (1500 to 2000 pills in 6 months). I have been able to have meaningful interventions with them and their families.

WA Prescription Monitoring Program

WAC 246-470-060 Law enforcement, prosecutorial officials, coroners, and medical examiners' access to information from the program. Local, state, or federal law enforcement officers and prosecutorial officials may obtain prescription monitoring information for a bona fide specific investigation involving a designated person. A local, state, or federal coroner or medical examiner may obtain prescription monitoring information for a bona fide specific investigation to determine cause of death.

HB 1637 Authorizes law enforcement and prosecutorial officials of federally recognized Indian tribes access to prescription monitoring data. Adds tribal LE and Prosecutorial officials to the list of who can access the PMP for bona fide specific investigations. DOH/PMP prepared to move forward Access concurrent with rule making has been approved by AOG PMP vendor is looking for time available to do the work to create the appropriate access.

Start Here: www.doh.wa.gov/pmp

Program Staff: Chris Baumgartner, Program Director Gary Garrety, Operations Manager Contact Info: PROGRAM CONTACTS Phone: 360.236.4806 Email: prescriptionmonitoring@doh.wa.gov Website: http://www.doh.wa.gov/pmp